All In Biotech

Drug Trial Radar · NCT03739528

Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery

An International, Multicenter, Randomized, Blinded-assessor, Parallel-group Clinical Study Comparing Eye Drops of Combined LEvofloxAcin + DExamethasone foR 7 Days Followed by Dexamethasone Alone for an Additional 7 Days vs. Tobramycin + Dexamethasone for 14 Days for the Prevention and Treatment of Inflammation and Prevention of Infection Associated With Cataract Surgery in Adults - LEADER 7

Last checked: Nov 19, 2026Latest source record: Aug 18, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 808 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

808

Actual

Start

Sep 3, 2018

Primary completion

Dec 19, 2018

Study completion Dec 19, 2018

Sponsor

Lead sponsor
NTC srlIndustry
Sponsor type
Industry
First posted
Nov 14, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
All sexes, from 40 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to demonstrate the non-inferiority of the study treatment (combined levofloxacin + dexamethasone eye drops) followed by dexamethasone eye drops alone vs. standard treatment in the prevention and treatment of postoperative ocular inflammation and prevention of infection.

Conditions

  • Cataract

Interventions

  • Levofloxacin + dexamethasone followed by dexamethasoneDrug

    Levofloxacin + dexamethasone ophthalmic solution for 7 days, 1 drop - 4 times a day, followed by dexamethasone ophthalmic suspension (Maxidex®) for an additional 7 days, 1 drop - 4 times a day.

  • Tobramycin + DexamethasoneDrug

    Tobramycin + dexamethasone ophthalmic suspension (Tobradex®) for 14 days, 1 drop - 4 times a day.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants Without Signs of Anterior Chamber InflammationTime frame: Day 15

Locations

57 sites in 1 country. Site status is shown where the registry gives one.

  • Az. Osp. di Rilievo Nazionale "A. Cardarelli" di Napoli

    Naples, Italy

  • A.O.U. "Maggiore della Carità" di Novara

    Novara, Italy

  • A.O.U. Senese - Università degli Studi di Siena

    Siena, Italy

  • A.O.U. Osp. Riuniti Umberto I - G.M. Lancisi - G. Salesi - Università degli Studi di Ancona

    Ancona, AN, Italy

  • Ospedale della Murgia "Fabio Perinei" di Altamura

    Altamura, BA, Italy

  • A.O.U. Policlinico Consorziale di Bari

    Bari, BA, Italy

  • ASL Bari - Ospedale "Di Venere" - Carbonara di Bari

    Bari, BA, Italy

  • Cliniche Gavazzeni S.p.A. - Humanitas Gavazzeni di Bergamo

    Bergamo, BG, Italy

  • A.O.U. di Bologna - Policlinico S. Orsola-Malpighi di Bologna

    Bologna, BO, Italy

  • Policlinico S. Orsola-Malpighi di Bologna

    Bologna, BO, Italy

  • ASST degli Spedali Civili di Brescia - P.O. Spedali Civili di Brescia

    Brescia, BS, Italy

  • ASST Franciacorta - P.O. di Chiari

    Chiari, BS, Italy

  • P.O. Ospedale Clinicizzato SS. Annunziata di Chieti

    Chieti, CH, Italy

  • Ospedale Valduce di Como

    Como, CO, Italy

  • A.O.U. Policlinico Vittorio Emanuele - P.O. Gaspare Rodolico - Università degli Studi di Catania

    Catania, CT, Italy

  • Policlinico G.B. Morgagni di Catania - Casa di Cura s.r.l.

    Catania, CT, Italy

  • A.O. Mater Domini di Catanzaro - Università degli Studi Magna Graecia di Catanzaro

    Catanzaro, CZ, Italy

  • IRCCS Casa Sollievo della Sofferenza di San Giovanni Rotondo

    San Giovanni Rotondo, FG, Italy

  • A.O.U. Careggi di Firenze

    Florence, FI, Italy

  • IRCCS Ospedale Policlinico San Martino di Genova

    Genova, GE, Italy

  • Ospedale Policlinico San Martino - Università degli Studi di Genova

    Genova, GE, Italy

  • Fatebenefratelli - Ospedale "Sacra Famiglia" di Erba

    Erba, LC, Italy

  • Az. USL Toscana Nord Ovest - Ospedale della Versilia

    Lido di Camaiore, LU, Italy

  • AUSL Toscana Nord Ovest - P.O. San Luca di Lucca

    San Filippo, LU, Italy

  • A.O.U. Policlinico "G. Martino" di Messina

    Messina, ME, Italy

  • ASP di Messina - P.O. "Giuseppe Fogliani" di Milazzo

    Milazzo, ME, Italy

  • ASST Ovest Milanese - Ospedale Civile di Legnano

    Legnano, MI, Italy

  • IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano

    Milan, MI, Italy

  • Gruppo Multimedica - Ospedale San Giuseppe di Milano

    Milan, MI, Italy

  • Ospedale San Raffaele IRCCS S.r.l.

    Milan, MI, Italy

  • ASST Fatebenefratelli Sacco - Università degli Studi di Milano - Ospedale L. Sacco

    Milan, MI, Italy

  • IRCCS Istituto Clinico Humanitas di Rozzano

    Rozzano, MI, Italy

  • ASST di Melegnano e della Martesana - Ospedale di Vizzolo Predabissi

    Vizzolo Predabissi, MI, Italy

  • A.O.U. Policlinico di Modena - Università degli Studi di Modena e Reggio Emilia

    Modena, MO, Italy

  • Ospedale di Sassuolo

    Sassuolo, MO, Italy

  • Centro Polispecialistico Monterosso di Carrara

    Carrara, MS, Italy

  • A.O.U. Policlinico "P. Giaccone" di Palermo

    Palermo, PA, Italy

  • A.O. "Ospedali Riuniti Villa Sofia-Cervello" di Palermo - P.O. "Villa Sofia" di Palermo

    Palermo, PA, Italy

  • AUSL di Piacenza - Ospedale "Guglielmo da Saliceto" di Piacenza

    Piacenza, PC, Italy

  • Az. ULSS 6 Euganea - Ospedale S. Antonio - Centro Oculistico San Paolo di Padova

    Padova, PD, Italy

Showing 40 of 57 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.